Feb 27, 2020 / 01:00PM GMT
Andrew Scott Kligerman - Crédit Suisse AG - Research Division - MD & Senior Life Insurance Analyst
Great. Okay. Hi, I'm Andrew Kligerman, the equity life insurance analyst at Crédit Suisse. And it's great to have Dan Amos here. He's just kind of looking at the bio. And Dan has been CEO for 30 years at the company with EPS over that time frame that are up well over 1,000%. And a lot of people look at Aflac and see some challenges in both Japan and the U.S. I look at a CEO who has met every challenge, and we're excited to hear about some of the initiatives in the U.S. and Japan and some of the really interesting things like the corporate partnerships, which involve insurtech and then a strategy of buying to build. And just excited to have Dan here. So all set to hear from you.
Daniel Paul Amos - Aflac Incorporated - Chairman & CEO
Thank you, Andrew, and good morning, everyone. It's a pleasure to be here. Today, I'd like to tell you about Aflac's strategy, operations, recent performance, and how we plan to grow while returning
Aflac Inc at Credit Suisse Financial Services Forum Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot